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Introduction.
Elevated titers of natural antibodies have been
demonstrated in the sera of patients following trartsplantation.1 - 6 These humoral responses were thought
to be associated with rejection .1 - 10 This concept was
challenged by investigators whose studies associated
these responses with infection or with injection of
heterologous serum .11 - 15 Nevertheless, the possible
prognostic significance of these relatively simple tests
has continued to evoke interest.
This study was undertaken to compare the humoral responses in three different groups of patients
with organ transplants in order to evaluate the influence of duration of the homograft and the attend a nt immunosuppression .

Materials and Methods.
Patient Selection.
Fifty-eight patients who had received homografts were selected for study. The patients were divided into three groups: Group 1, 20 patients tested
prior to transpla ntation and in the immediate posttranspl a nt period with a mean duration of follow-up
of 3.3 months; Group 2, 19 patients tested approximately five to seven years following transplantation
with a mean follow-up duration of 82.2 months; and
Group 3, 19 patients tested approximately ten years
following transplantation with a mea n follow-up duration of 118.1 months .

Correspondence and reprint requests to Dr. Marion Waller,
Box 263 , Medical Co llege of Virginia, Richmond , Virginia 23298.

32

Tests for Anti-Rat Erythrocyte Antibodies ( Heterophil Antibodies).
Rat erythrocytes were washed three times in saline and reconstituted to a 2% suspension . The test
sera were tested at a 1: 20 dilution and in serial twofold dilution for antibody titer. The tubes were allowed to stand at room temperature for 30 mintues,
spun for 1 minute at 77 g, and .read with the naked
eye.

Tes ls for Rheumatoid Factor ( A nti-Fc IgG antig/obulins ).
The sensitized human cell test (SHC) was used.
A selected DCe/ DCe test cell was sensitized with
Ripley serum (high titered antiDC) diluted 1: 10. The
Rh-positive cells were sensitized for 60 minutes at 37
C and then washed three times in saline. Test sera
were titrated in saline in 0.1 ml volumes. Titers of
I : 20 or above were considered positive.
0

Tests for Chymotrypsin Agglutinators ( Anti-Fab
IgG Antig/obulins) Hydrolysis of IgG globulins.
The IgG globulins of anti-Rh serum (Ripley)
were isolated by (N H4)2S04 precipitation followed by
chromatography on diethylaminoethyl (DEAE)-cellulose as previously described. 16 Methods of hydrolysis of the IgG globulins with chymotrypsin have
been reported. 17

Sensitizations. One milliliter (containing 5 mg of
digested globulin) was added to 0.1 ml of human 0,
DCe/ DCe washed packed cells a nd sensitized at 37 C
for one hour. The sensitized cells were washed three
times with saline and reconstituted to a 2% suspension. The cells were tested with goat anti-Fe and antiFab (Hyland Laboratories, Los Angeles, California)
antisera.
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Methods of testing. Tests for serum agglutinators
were performed in tubes by adding 0 . 1 ml aliquots of
the sensitized cells to an equal volume of undiluted
an d serial twofold dilutions of sera to be tested. The
mixture was allowed to stand at room temperature
for ten minutes, and then spun for one minute at 77 g
and read with the naked eye.
Erythrocyte Sedimentation Rate ( ESR).
The Westergren method was used to document
the ESR . The fall of the erythrocytes in millimeters in
one hour was noted . The normal sedimentation rate
with this method is O to 15 mm for men with an
average of 4 mm, and Oto 20 mm for women with an
average of 5 mm.

Nitroblue-Tetrazolium Test ( NBT) .
The NBT test was performed according to the
modified method of Dorwick' 8 on venous blood collected in 4.5 ml vacutainers containing 3.8% sodium
citrate. The NBT test was performed as soon as possible after the blood was drawn in order to eliminate
morphological changes caused by prolonged exposure to the anticoagulant.
A standard so lution of 0.4% N BT was prepared
in a 10 ml stoppered volumetric flask by dissolving 20
mg of nitroblue tetrazolium (Grade Ill reagent,
N6876, Sigma Chemical Co., St. Louis, Missouri) in
5 ml of sterile 0.85% isotonic saline. To dissolve the
NBT, the stoppered flask was sw irled under hot, running tap water until the solution beca me clear. This
solution was then filtered and transferred to a brown
bottle and stored at 4°C. The solution was stable for
72 hours .
Citrated blood, 0.2 ml, was placed in a test tube
and 0.1 ml of 0.4% NBT was added. The tube was
mixed by gently shaking, capped and incuba ted in a
water bath at 37 C for 30 minutes . The tube was
removed from the water bath, and one drop of the
blood-NBT test mixture was added to two precleaned, la beled glass slides. Special care was taken to
avoid damage to the white blood cells . The slides
were air-dried and stained with Wright's stain. The
stained slides were examined microscopica lly using
an oil immersion lens and 100 neutrophils were
counted. Neutrophils were classified as "NBT-positive" if they contained any visible formazan deposits .
Cells that were disrupted or clumped together were
not counted . The percent of N BT-positive neutrophils was reported as 0% to 15% normal and 16% to
I 00% normal.

Serum Electrophoresis.
Serum electrophoresis was performed on cellulose acetate strips, using the Microzone cell, Model
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R-101 (Beckman Instruments , Inc., Fullerton , California).
Results.
Figure I shows the humoral responses of the 20
patients in Group I during the first five to six months
following transplantation. The anti-Fab antiglobulins are design ated by dark circles. These antibodies
are usually produced as lgG globulins. Only 7 of the
20 patients showed titers at any time in excess of the
pretranspl a nt values. Titers below I: 20 are shown as
lines without a dot dipping below the I: 20 titer level.
Fluctuations in titer are common.
The a nti-rat erythrocyte a ntibodies are designated by open circles. These antibodies are almost
always produced as lgM globulins. Fifty percent (10
out of 20) of the patients showed titers in the posttransplant period higher than the pretransplant titer.
Once again, fluctuations in titer are common. There
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Fig I-Titers of anti-rat erythrocyte a ntibodi es a nd chym otrypsin
agg lutin ators in 20 patients in the immediate post-transplant period. Open circle: anti-rat erythrocyte: Dark circle: chymotrypsin
agglu tin ato rs.
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is a tendency for both antibodies to return toward
pretransplant levels 9 to 12 months after transplantation.
Although 4 of these 20 patients gave positive
tests for rheumatoid factors, on ly 3 (patients 2, 7 and
13) showed titers in excess of the pretransplant values. Titers were not constant, as is observed in
chronic rheumatoid arthritis, but fluctuated, cresting
and then falling, like the other antibodies. The rheumatoid factors were invariably made as IgM globulins.
Modestly elevated titers of anti-sheep erythrocyte antibodies ( I : 80) were found in only 2 (patients 3 and 11) of the 20 patients.
The blood groups of the 58 patients did not
significantly influence the serological responses of the
antibodies tested .
Figure 2 shows the titers of the anti-rat erythrocyte antibodies (lgM globulins) and the anti-Fab
antiglobulins (IgG globulins) in the three groups of
patients in order of increasing duration of the homograft and attendant immunosuppression. The titers of
the antibodies in Group I were read at three months
post-transplant. The titers of Groups 2 and 3 were
performed when they appeared for post-transplant
check-up. It is apparent from Figure 2 that the number of patients with significant titers of antibodies
decreases with duration of the homograft.
Three of the 38 long-term homograft recipients
(five to ten years) had positive tests for rheumatoid
factors. Neither the presence nor the titers of the
rheumatoid factors were related to the duration of
the graft. One patient who had shown high titers of
rheumatoid factors in the past lost this activity 11
years post-transplant. This patient has developed reticulum cell sarcoma.
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TABLE I
a) Relationship of level of gamma globulins to
/gG antibody production as chymotrypsin agglutinator
< 12%

> 12%

Total

5/ 6
2/ 11
0/ 6

9/ 14
3/ 8
5/ 13

14/ 20(70%)
5/ 19 (26% )
5/ 19 (26% )

66

b) Relationship of level of gamma globulins to
lg M antibody production as anti-rat antibody

6
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•
••
••••
••••
••••

Electrophoretic patterns of tlie serum proteins
were performed on the three groups of patients. The
patients were divided into two groups, those with
gamma globu lin s below 12% and those with gamma
globulins above 12% (Table I) . In Group I, 5 out of
the 6 patients with gamma globulin levels below 12%
made anti-Fab IgG antibodies as did 9 out of the 14
with gamma globulin levels above 12%. Thus, 70% of
Group I made these antibodies. However, in Group
2, only 2 out of 11 ma de these antibodies when the
level of gamma g lobu lin was below 12%, while 3 out
of 8 made them when the level of gamma globulin
was above 12%. In the whole group, 26% made these
antibodies. In Group 3, none of the 6 patients with
gamma globulin levels below 12% made these IgG
antibodies, while 5 of the 13 with gamma g lobu lin
levels above 12% did so .
A similar pattern is seen for the IgM anti-rat
erythrocyte antibodies. There appears to be no effect
of low levels of gamma globulin in the immediate
post-transplant group (Group I), but in the longterm patients, the influence of low levels of gamma
globulin on both the lgG and lgM antibodies is demonstrable.
Table 2 shows the relationship between the serum creatinine levels and the failure to show humoral
responses in 37 of the long-term transplant recipients .
Among the 12 patients with elevated levels of creatinine, the incidence of both IgG and lgM antibodies is
decreased . This decrease in antibody production was
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Fig 2-lnfluence of duration .of homograft and attendant immunosuppression on humoral antibodies in 58 patients. Triangle: mean
3.3 months: Dark square: mean 82.2 months; Open square: 118.1
month s.

Group 1*
Group 2**
Group 3***

< 12%

> 12%

Total

6/ 6

10/ 14
3/ 8
6/ 13

16/ 20 (80% )
5/ 19 (26%)
7 / 19 (37%)

2/ 11
1/ 6

* Mean 3.3 month s
•• Mean 82.2 months
*** Mean 118.1 months
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TABLE 2
Thirty-seven patients with long-term homografts showing a relationship between the serum creatinine level and failure to show humoral responses
IgM Antibody Responses
(anti-rat erythrocyte antibody)
Creatinine levels:

3.1 and above
0/ 3

2.1-2.5
0/ 2

2.6-3.0
0/ 1

1.5-2.0
1/ 6

0.9-1.4
11 / 25

1.5-2.0
0/ 6

0.9-1.4
I 0/ 25

IgG Antibody Responses
(chymotrypsin agglutinators)
Creatinine levels:

3.1 and above
0/ 3

2.7-3.0
0/ 1

not related to a significantly higher dose of maintenance immunosuppression .
Since infection plays a prominent role in patients
maintained for long periods on immunosuppressive
agents, the erythrocyte sedimentation rate and the
NBT test were performed on 37 of the 38 patients in
Group 2 and 3. The erythrocyte sedimentation test
was abnormal in 24 of the 37 patients (65%). The
numerous factors affecting this test, such as anemia
and dysglobulinemia, lessen the value of this test for
evaluation of patients with positive tests. The NBT
test was only positive in 3 of the 37 long-term patients. Careful review of the discharge summaries
corresponding to the period at which the test was
done failed to reveal a reason for these abnormal
tests. In a further effort to evaluate the significance of
these positive tests, C3 and C4 levels were determined
on these patients' sera along with 12 other patients
who did not show positive NBT tests. The levels of
C3 and C4 were not significantly altered in the patients with positive NBT tests.
Discussion.
These studies document humoral antibody activity in the immediate post-transplant period. Rises in
titer of both IgG antibodies (anti-Fab lgG antiglobulins) and lgM antibodies (anti-rat erythrocyte antibodies) are demonstrable. The antibody rises are usually inverse to each other, implying that different
antigens elicit these responses. The antigens on the
rat erythrocyte are also found on dog and rabbit
erythrocytes, and related antigens are present on human B erythrocytes. Thus, the antibodies are termed
heterophils . McDonald and co-workers 19 recently
studied these antibodies and related the absence of
the "rat" antigen (HT-A) in the recipients to increased rejection of kidneys from donors with the
antigen . Their studies have clinical importance and
help to define complex tissue antigens which will
receive more attention in the future.
Rises in titer of the anti-Fab lgG antiglobulins

2.1-2.5
0/ 2

could not be closely associated with rejection. These
antiglobulins are associated with severe suppurative
infection in a hospitalized population. 16 In posttransplant patients, there is a tendency for these antiglobulins to rise when the titers of the anti-rat erythrocyte antibodies are falling, 14 which suggests that
these are auxiliary immune responses or responses to
antibody-antigen complexes.
The dramatic serological responses in the immediate post-transplant period are not repeated in subsequent years. This is probably due to immunosuppressivt: therapy. However, we observed no inhibition
of polymorphonuclear phagocytosis nor depression
of C3 or C4 levels. On the other hand, laboratory
tests for infection (sedimentation rate, NBT test) may
react nonspecifically, making the diagnosis of occult
infection difficult.
As all those interested in transplantation know,
the greatest drawback in currently available methods
of immunosuppression is their nonspecificity. This
fact has stimulated interest in immunological enhancement of the kidney graft. Evidence exists that
kidney grafts in rats can survive by virtue of enhancement.20-25 One approach in humans entailed the production of immune sera to leukocyte antigens, followed by the hydrolysis of the antibody to remove the
complement-fixing Fe fragment. The resulting Fab
fragments were injected into the recipient to bind to
the antigenic sites on the graft. 26 As discussed previously, the serum agglutinators are antiglobulins
which have specificity for Fab fragments following
hydrolysis. These antiglobulins are naturally occurring lgG globulins commonly found in low titer.
However, the serum agglutinators (named homoreactant in rabbits) are not apparently stimulated by the
injection of Fab fragments, 27 but once stimulated,
their ability to reconstitute the biological potential of
the Fab fragment has been established. 28 Therefore, it
would be essential to test the recipient for these antiglobulins prior to the injection of the Fab fragments .
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In any case, the role of the anti-Fab antiglobulins
must be considered when Fab fragments are used to
achieve blocking of the antigenic sites of a homograft.
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